C
Novo Nordisk A/S NVO
$54.30 $0.020.04% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025
Revenue 6.14% -10.05%
Total Other Revenue -- --
Total Revenue 6.14% -10.05%
Cost of Revenue 7.47% 5.48%
Gross Profit 5.87% -12.59%
SG&A Expenses 26.15% -21.55%
Depreciation & Amortization -- --
Other Operating Expenses 277.15% 98.13%
Total Operating Expenses 19.12% -10.02%
Operating Income -7.02% -10.07%
Income Before Tax -1.57% 2.80%
Income Tax Expenses -1.56% 7.76%
Earnings from Continuing Operations -1.57% 1.52%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -1.57% 1.52%
EBIT -7.02% -10.07%
EBITDA -4.75% -4.99%
EPS Basic -1.65% 1.66%
Normalized Basic EPS -1.65% -11.61%
EPS Diluted -1.57% 1.69%
Normalized Diluted EPS -1.57% -11.55%
Average Basic Shares Outstanding 0.09% -0.15%
Average Diluted Shares Outstanding 0.01% -0.20%
Dividend Per Share -- --
Payout Ratio -- --